DE69130679T2 - Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation - Google Patents

Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Info

Publication number
DE69130679T2
DE69130679T2 DE69130679T DE69130679T DE69130679T2 DE 69130679 T2 DE69130679 T2 DE 69130679T2 DE 69130679 T DE69130679 T DE 69130679T DE 69130679 T DE69130679 T DE 69130679T DE 69130679 T2 DE69130679 T2 DE 69130679T2
Authority
DE
Germany
Prior art keywords
treatment
cell proliferation
compositions
diseases
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130679T
Other languages
English (en)
Other versions
DE69130679D1 (de
Inventor
Lawrence Blatt
Milton Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DE69130679D1 publication Critical patent/DE69130679D1/de
Publication of DE69130679T2 publication Critical patent/DE69130679T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
DE69130679T 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation Expired - Lifetime DE69130679T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59920690A 1990-10-17 1990-10-17
US77292291A 1991-10-15 1991-10-15
PCT/US1991/007722 WO1992006707A1 (en) 1990-10-17 1991-10-15 Methods and compositions for the treatment of cell proliferation disorders

Publications (2)

Publication Number Publication Date
DE69130679D1 DE69130679D1 (de) 1999-02-04
DE69130679T2 true DE69130679T2 (de) 1999-05-06

Family

ID=27083273

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130679T Expired - Lifetime DE69130679T2 (de) 1990-10-17 1991-10-15 Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation

Country Status (17)

Country Link
EP (1) EP0553294B1 (de)
JP (1) JP3496937B2 (de)
CN (1) CN1053117C (de)
AT (1) ATE174798T1 (de)
AU (1) AU660633B2 (de)
CA (1) CA2094275C (de)
DE (1) DE69130679T2 (de)
DK (1) DK0553294T3 (de)
ES (1) ES2128348T3 (de)
HK (1) HK1010340A1 (de)
IE (1) IE913656A1 (de)
IL (1) IL99778A (de)
NO (1) NO931413D0 (de)
NZ (1) NZ240264A (de)
PT (1) PT99265B (de)
SG (1) SG52537A1 (de)
WO (1) WO1992006707A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5372808A (en) * 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US20030053982A1 (en) 1994-09-26 2003-03-20 Kinstler Olaf B. N-terminally chemically modified protein compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US6013253A (en) * 1997-08-15 2000-01-11 Amgen, Inc. Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
US7232805B2 (en) * 2003-09-10 2007-06-19 Inflabloc Pharmaceuticals, Inc. Cobalamin conjugates for anti-tumor therapy
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
MXPA06013412A (es) 2004-05-19 2007-01-23 Maxygen Inc Polipeptidos de interferon-alfa y conjugados.
MY167668A (en) * 2005-03-09 2018-09-21 Superlab Far East Ltd Uses of recombinant super-compound interferons
JP2008545393A (ja) 2005-05-18 2008-12-18 マキシジェン， インコーポレイテッド 進歩したインターフェロンαポリペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4879471A (en) * 1987-03-25 1989-11-07 Measurex Corporation Rapid-scanning infrared sensor

Also Published As

Publication number Publication date
NZ240264A (en) 1997-07-27
ATE174798T1 (de) 1999-01-15
NO931413L (no) 1993-04-16
NO931413D0 (no) 1993-04-16
EP0553294A4 (en) 1994-11-23
AU9023591A (en) 1992-05-20
IE913656A1 (en) 1992-04-22
SG52537A1 (en) 1998-09-28
IL99778A0 (en) 1993-02-21
PT99265B (pt) 1999-04-30
CA2094275C (en) 2003-06-03
CN1064018A (zh) 1992-09-02
DE69130679D1 (de) 1999-02-04
CA2094275A1 (en) 1992-04-18
PT99265A (pt) 1992-08-31
EP0553294B1 (de) 1998-12-23
CN1053117C (zh) 2000-06-07
AU660633B2 (en) 1995-07-06
IL99778A (en) 1996-11-14
WO1992006707A1 (en) 1992-04-30
ES2128348T3 (es) 1999-05-16
JP3496937B2 (ja) 2004-02-16
HK1010340A1 (en) 1999-06-17
JPH06502426A (ja) 1994-03-17
EP0553294A1 (de) 1993-08-04
DK0553294T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
FI20115753A (fi) Farmaseuttisia koostumuksia IL-6:n tuoton aiheuttamien sairauksien hoitoon
ATE94387T1 (de) Verwendung von n-myristoyl-(s)-phenylalanin zur herstellung eines medikaments zur behandlung von krankheiten mittels hemmung der myristoylierung.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
FI922770A (fi) Bcrf1-proteinerna som inhibitorer av y-interferon.
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition